Every cell in your body is running on a molecule you’ve probably never thought about. It’s called NAD+—nicotinamide adenine dinucleotide—and without it, you’d be dead within seconds. It powers your metabolism, repairs your DNA, regulates your genes, and coordinates your cells’ response to stress. It is, without exaggeration, one of the most fundamental molecules in all of biology.
And it’s disappearing. By the time you’re 50, you have roughly half the NAD+ you had at 20. By 80, you may have less than a quarter. Researchers now believe this decline isn’t just a side effect of aging—it may be one of its primary drivers. Understanding why NAD+ falls, what it does, and how to preserve or restore it has become one of the most active areas in longevity science.
What NAD+ Actually Does Inside Your Cells
NAD+ is a coenzyme, which means it doesn’t do a job directly—it enables other molecules to do theirs. It exists in two forms: NAD+ (oxidized) and NADH (reduced). The ratio between them is a fundamental signal of your cell’s metabolic state.
In its most basic role, NAD+ is the electron carrier at the heart of energy production. During glycolysis and the citric acid cycle, NAD+ accepts electrons from food molecules, becoming NADH. That NADH then donates those electrons to the mitochondrial electron transport chain, which uses the energy to produce ATP—the universal fuel currency of life. Without adequate NAD+, this entire chain breaks down. Cells become energy-starved even when food is abundant.
But energy metabolism is only one of NAD+’s roles. It also serves as the required substrate—the fuel—for two critically important classes of enzymes:
Sirtuins: The Longevity Regulators
Sirtuins are a family of seven proteins (SIRT1–7) that regulate gene expression, stress responses, metabolism, and aging. They’re sometimes called “longevity genes” because manipulating them extends lifespan in virtually every organism studied, from yeast to mice.
Sirtuins are deacetylases—they remove acetyl groups from proteins, which changes those proteins’ activity. SIRT1 regulates mitochondrial biogenesis and inflammation. SIRT3 governs mitochondrial metabolism and antioxidant defenses. SIRT6 controls DNA repair and telomere maintenance. SIRT5 regulates ketone body metabolism.
The critical point: sirtuins are completely dependent on NAD+. Every sirtuin reaction consumes NAD+ as a substrate. No NAD+, no sirtuin activity. This means that as NAD+ declines with age, your sirtuins go quiet—and with them, the entire regulatory network they control.
PARPs: The DNA Repair Crew
PARP enzymes (poly ADP-ribose polymerases) detect DNA damage and orchestrate repair. PARP1, the most abundant, is constantly scanning your DNA for breaks, nicks, and lesions—which occur thousands of times per cell per day from normal metabolism, radiation, and oxidative stress.
When PARP1 finds damage, it consumes enormous amounts of NAD+. A single strand break can trigger a PARP1 response that depletes local NAD+ by 80% or more. This creates a fundamental tension: DNA damage—which accumulates with age—increasingly activates PARP1, which increasingly depletes NAD+, which decreases sirtuin activity, which impairs the DNA repair and stress response systems that sirtuins regulate. It’s a vicious cycle.
Why NAD+ Declines With Age
The drop in NAD+ with aging isn’t a single problem—it’s the convergence of multiple biological changes happening simultaneously.
CD38: The NAD+ Destroyer
CD38 is an enzyme that consumes NAD+, and its expression increases dramatically with age—largely due to chronic, low-grade inflammation. A 2016 paper in Cell Metabolism found that CD38 was the primary driver of NAD+ decline in aged mice. When researchers knocked out CD38 expression, old mice maintained youthful NAD+ levels and were protected from age-related metabolic dysfunction.
CD38 is activated by inflammatory signals—particularly those from senescent cells (zombie cells that accumulate with age and secrete inflammatory molecules). This creates another feedback loop: aging causes senescence, senescence causes inflammation, inflammation activates CD38, CD38 depletes NAD+, and low NAD+ impairs the cellular maintenance systems that would otherwise clear senescent cells.
PARP Overactivation
As mentioned, DNA damage accumulates with age. This means PARP1 is increasingly activated, consuming more and more NAD+ in repair operations. It’s a legitimate biological response to real damage—but it creates a resource competition that the cell increasingly loses.
Reduced Biosynthesis
Your body synthesizes NAD+ from precursors through several pathways. The salvage pathway—which recycles NAD+ breakdown products back into NAD+—is the most efficient. But the enzyme that drives this pathway, NAMPT (nicotinamide phosphoribosyltransferase), declines with age. Simultaneously, dietary tryptophan conversion to NAD+ via the de novo pathway becomes less efficient. The result: lower production combined with higher consumption.
The Consequences of NAD+ Decline
When you map what NAD+ does against what declines with aging, the overlap is striking.
Metabolic dysfunction. Lower NAD+ impairs mitochondrial function, reducing cellular energy output and promoting insulin resistance. Cells with dysfunctional mitochondria increasingly rely on glycolysis—the less efficient, more inflammatory metabolic pathway.
Impaired DNA repair. Without adequate NAD+, both PARP1 and the sirtuin SIRT6 (which also participates in DNA repair) become less effective. DNA damage accumulates faster than it can be fixed, accelerating mutation rates and genomic instability.
Mitochondrial deterioration. SIRT1 and SIRT3 are required for mitochondrial biogenesis (making new mitochondria) and mitophagy (clearing damaged ones). As NAD+ falls, these processes slow. Mitochondria accumulate damage and dysfunction, producing less energy and more reactive oxygen species.
Cognitive decline. The brain is extraordinarily energy-demanding. NAD+-dependent metabolism is critical for neuronal function. Declining NAD+ has been linked to reduced neurological resilience, and NAD+ precursors are being studied in Alzheimer’s, Parkinson’s, and age-related cognitive decline.
Reduced muscle function. SIRT1 is required for muscle fiber maintenance and metabolic flexibility in skeletal muscle. SIRT3 protects muscle mitochondria. Declining NAD+ contributes to the loss of muscle mass and function (sarcopenia) that characterizes aging—a process closely intertwined with cardiovascular fitness decline.
NAD+ Precursors: NMN vs. NR vs. Niacin
Because NAD+ itself doesn’t easily enter cells, researchers have focused on precursor molecules that the body converts to NAD+. The three main ones are:
Nicotinamide Riboside (NR)
NR is a form of vitamin B3 that enters cells via specific transporters and is phosphorylated to NMN, then to NAD+. The first human clinical trials demonstrated that NR supplementation reliably raises blood NAD+ levels. A 2018 study in Nature Communications by Elhassan et al. found that 1,000 mg/day NR for 21 days increased whole-blood NAD+ by approximately 40-60% in healthy middle-aged adults.
The clinical picture with NR is mixed. Studies have shown improvements in muscle NAD+ levels, and some research suggests benefits for blood pressure and arterial stiffness in older adults. However, large-scale trials showing meaningful clinical outcomes (not just biomarker changes) are still limited.
Nicotinamide Mononucleotide (NMN)
NMN sits one step closer to NAD+ in the biosynthetic pathway. David Sinclair’s lab at Harvard has published extensively on NMN in mice, showing remarkable results: NMN supplementation reversed age-related vascular dysfunction, improved muscle energy metabolism, and extended lifespan in aged mice.
Human data is catching up. A 2021 randomized controlled trial in Science by Yoshino et al. found that 250 mg/day NMN for 10 weeks improved muscle insulin sensitivity and increased expression of genes involved in muscle remodeling in postmenopausal women with prediabetes. A 2022 trial in older adults found that NMN improved muscle function and walking speed.
A key practical question: can NMN even enter cells directly, or must it be converted to NR first? Research in 2019 identified a specific NMN transporter (Slc12a8) in the small intestine, suggesting direct cellular uptake is possible. The debate isn’t fully resolved, but human pharmacokinetic data confirms NMN raises blood NAD+ efficiently.
Niacin (Nicotinic Acid) and Nicotinamide
These are the original vitamin B3 forms. Niacin is highly effective at raising NAD+ and has robust cardiovascular data—it was once a standard treatment for high cholesterol. The problem is flushing: niacin causes a prostaglandin-mediated skin flushing reaction that most people find unpleasant at therapeutic doses (500–2,000 mg/day).
Nicotinamide (niacinamide) doesn’t cause flushing and does raise NAD+ levels. However, it also inhibits sirtuins at high concentrations—which undermines the very mechanism through which increased NAD+ is supposed to work. This makes high-dose nicotinamide a poor choice for longevity purposes, though moderate doses from food are fine.
A newer form, nicotinamide riboside chloride (basis of the commercial supplement Tru Niagen) and various NMN formulations, attempts to capture NAD+-raising effects without the flushing or sirtuin inhibition problems.
Natural Ways to Boost NAD+
Before reaching for supplements, it’s worth noting that several lifestyle interventions reliably raise NAD+ levels through natural biological mechanisms.
Caloric Restriction and Fasting
Caloric restriction has been shown to increase NAD+ levels in multiple tissues. The mechanism involves AMPK activation—the cellular energy sensor—which upregulates NAMPT, the rate-limiting enzyme in the NAD+ salvage pathway. Time-restricted eating and intermittent fasting appear to produce similar effects through the same pathway.
This is part of why fasting has such broad metabolic effects: it simultaneously activates AMPK, which raises NAD+, which activates sirtuins, which regulate mitochondrial function, fat metabolism, and stress resistance. It’s a cascade triggered by perceived energy scarcity.
Exercise: The Most Potent NAD+ Booster
Both aerobic exercise and resistance training raise NAD+ levels in muscle. The mechanism is similar to fasting: exercise increases the AMP:ATP ratio, activating AMPK, which upregulates NAMPT expression. Studies show that regular exercise maintains NAMPT levels that would otherwise decline with age.
High-intensity interval training (HIIT) appears particularly effective, likely because the acute metabolic stress more strongly activates the AMPK cascade. A 2019 study found that HIIT training increased NAMPT protein levels in skeletal muscle by approximately 28% in older adults—effectively counteracting one of the primary mechanisms of age-related NAD+ decline. This is yet another reason why maximizing your VO2 max is so central to aging well.
Heat Exposure
Regular sauna use has been shown to activate heat shock proteins and SIRT1. While direct evidence for heat-induced NAD+ increases in humans is limited, sauna’s effects on cardiovascular health, metabolic function, and longevity biomarkers are consistent with improved NAD+ metabolism. The Finnish population studies—where sauna use 4-7 times per week was associated with dramatically reduced cardiovascular mortality—suggest mechanisms beyond simple relaxation.
Dietary Sources of NAD+ Precursors
Your body synthesizes NAD+ from tryptophan (via the kynurenine pathway) and from niacin-containing foods. Foods naturally rich in NAD+ precursors include:
Tryptophan sources: Turkey, chicken, eggs, dairy, pumpkin seeds, tofu, and legumes. Note that tryptophan → NAD+ conversion is inefficient (roughly 60:1 ratio), meaning diet alone rarely provides therapeutic amounts of NAD+ precursors, though it contributes to baseline levels.
Niacin-rich foods: Beef liver, chicken breast, tuna, salmon, peanuts, and whole grains. Adequate niacin intake from food keeps the salvage pathway supplied, though again, the amounts typically consumed in food aren’t sufficient to reverse age-related NAD+ decline on their own.
Reducing CD38 Activation
Since CD38 is the primary driver of age-related NAD+ consumption, reducing its activation is a logical strategy. CD38 is induced by inflammatory signals—which means that reducing chronic inflammation through diet, sleep, stress management, and avoiding ultra-processed foods directly preserves NAD+.
Some research suggests that certain natural compounds inhibit CD38 directly. Apigenin (found in parsley, chamomile, and celery) has shown CD38 inhibitory activity in vitro. Quercetin, a polyphenol found in onions and apples, has similar preliminary data. These effects haven’t been confirmed in large human trials, but their anti-inflammatory properties make them broadly beneficial regardless.
The Sinclair Hypothesis and Longevity Science
David Sinclair, geneticist at Harvard Medical School and author of Lifespan, has been the most prominent advocate for NAD+ as a central aging mechanism. His lab’s work has shown that restoring NAD+ levels in aged mice reverses multiple hallmarks of aging: vascular dysfunction, muscle weakness, impaired DNA repair, and metabolic decline.
Sinclair’s broader “information theory of aging” holds that the primary driver of aging isn’t DNA mutations per se, but the loss of epigenetic information—the instructions telling genes when and where to be expressed. Sirtuins, in his view, are the guardians of this epigenetic information. NAD+ decline, by silencing sirtuins, causes the epigenome to become increasingly noisy and dysregulated, driving the characteristic changes we associate with aging.
This is a compelling framework, though not without critics. Some researchers argue the mouse data doesn’t translate cleanly to humans, that the sirtuin-longevity connection is more complex than presented, and that the beneficial effects of NAD+ precursors in clinical trials are more modest than the mouse data suggested. The science is genuinely exciting, but humility is warranted about translating it to anti-aging prescriptions.
NAD+ and Metabolic Health
The connection between NAD+ and metabolic function is particularly well-documented. SIRT1 regulates FOXO transcription factors, PGC-1α (the master regulator of mitochondrial biogenesis), and NF-κB (a master regulator of inflammation). SIRT3 deacetylates and activates key enzymes in fatty acid oxidation and the citric acid cycle. Together, they maintain the metabolic flexibility—the ability to efficiently switch between glucose and fat as fuel—that deteriorates with age and metabolic disease.
In the context of insulin resistance, NAD+ depletion impairs the sirtuin-mediated regulation of insulin signaling, creating a bidirectional relationship: insulin resistance promotes the inflammation that depletes NAD+, and NAD+ depletion impairs the metabolic regulation that would otherwise prevent insulin resistance.
The Yoshino et al. 2021 Science paper mentioned earlier specifically found NMN improved muscle insulin sensitivity—a direct functional outcome, not just a biomarker change—which has been one of the more encouraging pieces of human evidence.
NAD+ and the Gut Microbiome Connection
Your gut microbiome plays a surprising role in NAD+ metabolism. Certain gut bacteria can synthesize NAD+ precursors, including NMN, which may be absorbed by intestinal cells. The specific NMN transporter (Slc12a8) identified in 2019 was found primarily in the small intestine—raising the possibility that gut bacteria contribute meaningfully to systemic NAD+ levels.
Dysbiosis—an imbalanced, less diverse microbiome—has been associated with increased intestinal inflammation and reduced short-chain fatty acid production, both of which promote CD38 activation and NAD+ consumption. Maintaining a healthy microbiome through fiber-rich diet, fermented foods, and avoiding unnecessary antibiotics thus has potential NAD+ benefits beyond its direct effects on digestion and immunity.
NAD+ and Sleep
NAD+ has a circadian dimension that’s often overlooked. SIRT1 and CLOCK proteins interact to regulate circadian rhythm gene expression. NAD+ levels themselves oscillate with a roughly 24-hour rhythm, tracking the activity of NAMPT, which is a direct clock-controlled gene.
This means poor sleep doesn’t just make you tired—it disrupts the circadian oscillation of NAD+ and sirtuin activity, potentially impairing DNA repair and metabolic regulation for hours after the disrupted night. Circadian misalignment—the chronic disruption common to shift workers and people with irregular schedules—may contribute to accelerated NAD+ decline through this mechanism.
Should You Supplement With NMN or NR?
This is the question most people arrive at after learning about NAD+ biology. The honest answer requires distinguishing between what the biology predicts, what animal studies suggest, and what human clinical trials have demonstrated.
What’s established: Both NR and NMN safely and reliably raise blood NAD+ levels in humans. The increases are dose-dependent and meaningful—often 40-80% above baseline with standard doses. No serious safety signals have emerged from trials lasting up to 12 weeks at doses up to 1,000–2,000 mg/day, though long-term safety data beyond this is limited.
What’s promising: Human trials have shown improvements in specific outcomes—muscle insulin sensitivity (NMN, Yoshino 2021), blood pressure and arterial stiffness (NR, Martens et al. 2018), muscle function in older adults (NMN, 2022 trial). These are real outcomes, not just biomarker changes.
What’s unresolved: We don’t have large, long-duration clinical trials showing that NAD+ precursor supplementation reduces meaningful clinical endpoints—cancer rates, cardiovascular events, all-cause mortality, cognitive decline—in humans. Mouse lifespan extension with NAD+ precursors has not yet been replicated as human longevity extension. Some human tissues (liver, blood cells) show clearer NAD+ increases than others (muscle, brain), and it’s unclear whether supplemental precursors reach all relevant compartments.
The practical consideration: If you’re going to supplement, the evidence slightly favors NMN over NR for muscle-specific outcomes (based on the Yoshino trial), though both are reasonable. Doses studied in humans: NR 500–1,000 mg/day; NMN 250–600 mg/day (some trials have used higher doses). These supplements are not cheap—expect to spend $50-100/month for quality products.
The honest cost-benefit calculus: if you’re already doing the foundational work—exercising regularly, sleeping well, eating whole foods, managing stress, avoiding ultra-processed foods—adding an NAD+ precursor is a reasonable, low-risk bet on mechanisms that are biologically plausible and have preliminary human evidence. If you’re not doing those things, the supplement is unlikely to compensate.
The Emerging Frontier: Senolytics and NAD+
One of the more promising directions in NAD+ research involves the relationship between senescent cells and CD38. Senescent cells—which accumulate with age and resist normal cell death—drive inflammation that activates CD38 and depletes NAD+. Senolytics are drugs or compounds that selectively eliminate senescent cells.
In mouse studies, combining senolytics with NAD+ precursors appears synergistic: senolytics reduce the inflammatory burden that activates CD38, while NAD+ precursors replenish what CD38 has consumed. Whether this combination will prove effective in humans is an active research question. The first human senolytic trials are ongoing, and their results will likely reshape how we think about NAD+ supplementation in aging.
Your NAD+ Optimization Protocol
Based on the current evidence, here’s how to approach NAD+ optimization across the hierarchy of interventions:
Tier 1 — Non-negotiables: Regular vigorous exercise (especially HIIT), adequate sleep with consistent timing, caloric moderation or time-restricted eating, and a diet rich in whole foods and fiber. These reliably increase NAMPT, reduce inflammation, and decrease CD38 activation through natural mechanisms. No supplement replaces these.
Tier 2 — Supporting interventions: Dietary niacin/tryptophan adequacy (animal protein, legumes, nuts), polyphenol-rich foods (quercetin, apigenin from parsley/chamomile/onions), and managing chronic inflammation through all available means. Ensure your gut microbiome is healthy.
Tier 3 — Optional supplementation: NMN (250-500 mg/day) or NR (500-1,000 mg/day) for those willing to invest in emerging longevity biology with promising but not definitive human evidence. If you have metabolic concerns (insulin resistance, metabolic syndrome), the Yoshino trial evidence is most applicable to you. If your primary concern is cardiovascular health, the NR arterial stiffness data is relevant.
The Bottom Line on NAD+
NAD+ is one of the most compelling targets in aging biology. Its roles in energy metabolism, DNA repair, epigenetic regulation, and stress response make it a genuine candidate for a master regulator of biological aging. The age-related decline is real, measurable, and mechanistically connected to many of the things we associate with getting old.
The evidence for supplemental NAD+ precursors is more advanced than for most longevity supplements—we have human clinical trials showing biological activity and some functional outcomes. But we don’t yet have the long-term, large-scale trials needed to make confident claims about extending human healthspan or lifespan.
What we do have is good evidence that the behaviors most reliably associated with healthy aging—exercise, sleep, a whole-food diet, stress management, fasting protocols—all work partly through maintaining or restoring NAD+ levels. Whether you decide to supplement or not, protecting your NAD+ through these foundational habits is one of the most evidence-supported things you can do to slow your cells’ biological clock.
The science of longevity is moving faster than ever. If you found this useful, explore the complete series: inflammation, insulin resistance, gut microbiome, VO2 max, and chronic stress.
